Alembic Pharmaceuticals Ltd reported a robust 29 percent increase in consolidated net profit for the fourth quarter ended March 31, reflecting sustained revenue growth across its business segments. The company posted quarterly net profit of Rs 202.7 crore compared with Rs 156.89 crore in the corresponding period last year. Revenue from operations also rose to Rs 1,847.72 crore, highlighting resilient demand and steady operational performance despite rising expenses.